1.
|
14 p, 1007.9 KB |
A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT) : initial results from an international prospective study
/
Bancroft, Elizabeth K (Royal Marsden NHS Foundation Trust, London) ;
Page, Elizabeth C (Institute of Cancer Research, London) ;
Brook, Mark N (Institute of Cancer Research, London) ;
Thomas, Sarah (Royal Marsden NHS Foundation Trust, London) ;
Taylor, Natalie (Royal Marsden NHS Foundation Trust, London) ;
Pope, Jennifer (Institute of Cancer Research, London) ;
McHugh, Jana (Institute of Cancer Research, London) ;
Jones, Ann-Britt (Institute of Cancer Research, London) ;
Karlsson, Questa (Institute of Cancer Research, London) ;
Merson, Susan (Institute of Cancer Research, London) ;
Ong, Kai Ren (Birmingham Women's Hospital) ;
Hoffman, Jonathan (Birmingham Women's Hospital) ;
Huber, Camilla (Birmingham Women's Hospital) ;
Maehle, Lovise (Oslo University Hospital (Oslo, Noruega)) ;
Grindedal, Eli Marie (Oslo University Hospital (Oslo, Noruega)) ;
Stormorken, Astrid (Oslo University Hospital (Oslo, Noruega)) ;
Evans, D Gareth (University of Mancheste) ;
Rothwell, Jeanette (University of Manchester) ;
Lalloo, Fiona (University of Manchester) ;
Brady, Angela F (London North West University Healthcare NHS Trust, Harrow) ;
Bartlett, Marion (London North West University Healthcare NHS Trust, Harrow) ;
Snape, Katie (St George's Hospital, Tooting, London) ;
Hanson, Helen (St George's Hospital, Tooting, London) ;
James, Paul (The University of Melbourne) ;
McKinley, Joanne (Parkville Familial Cancer Centre, Melbourne) ;
Mascarenhas, Lyon (Parkville Familial Cancer Centre, Melbourne) ;
Syngal, Sapna (Brigham and Women's Hospital (Boston, Estats Units d'Amèrica)) ;
Ukaegbu, Chinedu (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ;
Side, Lucy (Wessex Princess Anne Hospital, Southampton) ;
Thomas, Tessy (Princess Anne Hospital, Southampton) ;
Barwell, Julian (University Hospitals Leicester, Leicester) ;
Teixeira, Manuel R (Porto University, Porto) ;
Izatt, Louise (Guy's and St Thomas' NHS Foundation Trust, London) ;
Suri, Mohnish (Nottingham University Hospitals NHS Trust, Nottingham) ;
Macrae, Finlay A (Royal Melbourne Hospital (Melbourne, Austràlia)) ;
Poplawski, Nicola (University of Adelaide, Adelaide) ;
Chen-Shtoyerman, Rakefet (Ariel University, Ariel) ;
Ahmed, Munaza (Institute of Child Health, London) ;
Musgrave, Hannah (Leeds Teaching Hospitals NHS Trust, Leeds) ;
Nicolai, Nicola (Fondazione IRCCS Istituto Nazionale dei Tumori, Milano) ;
Greenhalgh, Lynn (Clinical Genetics Service, Liverpool Women's Hospital, Liverpool) ;
Brewer, Carole (Royal Devon & Exeter Hospital (Exeter, Regne Unit)) ;
Pachter, Nicholas (University of Western Australia, Perth) ;
Spigelman, Allan D (St Vincent's Hospital, Sydney) ;
Azzabi, Ashraf (Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne) ;
Helfand, Brian T (NorthShore University HealthSystem, Evanston) ;
Halliday, Dorothy (Oxford University Hospitals NHS Trust) ;
Buys, Saundra (University of Utah, Salt Lake City) ;
Ramon y Cajal, Teresa (Institut d'Investigació Biomèdica Sant Pau) ;
Donaldson, Alan (St Michael's Hospital, Bristol) ;
Cooney, Kathleen A (Duke Cancer Institute and Duke University School of Medicine, Durham) ;
Harris, Marion (Monash University, Clayton) ;
McGrath, John (University of Exeter Medical School, Exeter) ;
Davidson, Rosemarie (Queen Elizabeth University Hospital, Glasgow) ;
Taylor, Amy (Cambridge University Hospitals NHS Trust, Cambridge) ;
Cooke, Peter (New Cross Hospital, Wolverhampton, UK) ;
Myhill, Kathryn (Royal Marsden NHS Foundation Trust, London) ;
Hogben, Matthew (Royal Marsden NHS Foundation Trust, London) ;
Aaronson, Neil K (The Netherlands Cancer Institute, Amsterdam) ;
Ardern-Jones, Audrey (Royal Marsden NHS Foundation Trust, London) ;
Bangma, Chris H (Erasmus Cancer Institute, Rotterdam) ;
Castro, Elena (Spanish National Cancer Research Center, Madrid) ;
Dearnaley, David (The Institute of Cancer Research, Sutton) ;
Dias, Alexander (Instituto Nacional de Cancer Jose de Alencar Gomes da Silva INCA, Rio de Janeiro) ;
Dudderidge, Tim (University Hospital Southampton) ;
Eccles, Diana M (University of Southampton, Southampton) ;
Green, Kate (University of Manchester, Manchester) ;
Eyfjord, Jorunn (University of Iceland, Reykjavik) ;
Falconer, Alison (Imperial College Healthcare NHS Trust, London) ;
Foster, Christopher S (HCA Pathology Laboratories, London) ;
Gronberg, Henrik (University Hospital of Umeå) ;
Hamdy, Freddie C (University of Oxford) ;
Johannsson, Oskar (Landspitali - the National University Hospital of Iceland, Reykjavik) ;
Khoo, Vincent (The Institute of Cancer Research, Sutton, Surrey) ;
Lilja, Hans (Department of Laboratory Medicine, Memorial Sloan-Kettering Cancer Center, New York) ;
Lindeman, Geoffrey J (The Walter and Eliza Hall Institute of Medical Research, Parkville) ;
Lubinski, Jan (Pomeranian Medical University in Szczecin) ;
Axcrona, Karol (Department of Urology, Akershus University Hospital, Lørenskog) ;
Mikropoulos, Christos (Royal Surrey County Hospital, Guildford) ;
Mitra, Anita V (University College London Hospitals NHS Foundation Trust, London) ;
Moynihan, Clare (Institute of Cancer Research, London) ;
Ni Raghallaigh, Holly (Institute of Cancer Research, London) ;
Rennert, Gad (CHS National Cancer Control Center, Haifa) ;
Collier, Rebecca (Nottingham University Hospitals NHS Trust) ;
Offman, Judith (King's College London) ;
Kote-Jarai, Zsofia (Institute of Cancer Research) ;
Eeles, Rosalind A (Royal Marsden NHS Foundation Trust, London) ;
Universitat Autònoma de Barcelona
Lynch syndrome is a rare familial cancer syndrome caused by pathogenic variants in the mismatch repair genes MLH1, MSH2, MSH6, or PMS2, that cause predisposition to various cancers, predominantly colorectal and endometrial cancer. [...]
2021 - 10.1016/S1470-2045(21)00522-2
The Lancet. Oncology, Vol. 22 (november 2021) , p. 1618-1631
|
|
2.
|
14 p, 2.9 MB |
Exploring the link between MORF4L1 and risk of breast cancer
/
Martrat, Griselda (Institut d'Investigació Biomèdica de Bellvitge) ;
Maxwell, Christopher A. (Institut d'Investigació Biomèdica de Bellvitge) ;
Tominaga, Emiko (The University of Texas Health Science Center at San Antonio) ;
Porta de la Riva, Montserrat (Institut d'Investigació Biomèdica de Bellvitge) ;
Bonifaci, Núria (Institut d'Investigació Biomèdica de Bellvitge) ;
Gomez-Baldo, Laia (Institut d'Investigació Biomèdica de Bellvitge) ;
Bogliolo, Massimo (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ;
Lazaro, Conxi (Institut d'Investigació Biomèdica de Bellvitge) ;
Blanco Guillermo, Ignacio (Institut d'Investigació Biomèdica de Bellvitge) ;
Brunet, Joan (Hospital Universitari de Girona Doctor Josep Trueta) ;
Aguilar, Helena (Institut d'Investigació Biomèdica de Bellvitge) ;
Fernández-Rodríguez, Juana (Hospital Universitari de Girona Doctor Josep Trueta) ;
Seal, Sheila (Institute of Cancer Research (Sutton, Regne Unit)) ;
Renwick, Anthony (Institute of Cancer Research (Sutton, Regne Unit)) ;
Rahman, Nazneen (Institute of Cancer Research (Sutton, Regne Unit)) ;
Kühl, Julia (University of Würzburg. Department of Human Genetics (Würzburg, Alemanya)) ;
Neveling, Kornelia (University of Würzburg. Department of Human Genetics (Würzburg, Alemanya)) ;
Schindler, Detlev (University of Würzburg. Department of Human Genetics (Würzburg, Alemanya)) ;
Ramírez de Haro, Ma. José (María José) (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ;
Castellà, María (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ;
Hernández Viedma, Gonzalo (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ;
Easton, Douglas F. (University of Cambridge. Department of Public Health and Primary Care) ;
Peock, Susan (University of Cambridge. Department of Public Health and Primary Care) ;
Cook, Margaret (University of Cambridge. Department of Public Health and Primary Care) ;
Oliver, Clare T. (University of Cambridge. Department of Public Health and Primary Care) ;
Frost, Debra (University of Cambridge. Department of Public Health and Primary Care) ;
Platte, Radka (University of Cambridge. Department of Oncology) ;
Evans, D. Gareth (Central Manchester University Hospitals NHS Foundation Trust (Manchester, Regne Unit)) ;
Lalloo, Fiona (Central Manchester University Hospitals NHS Foundation Trust (Manchester, Regne Unit)) ;
Eeles, Rosalind (The Institute of Cancer Research (Sutton, Regne Unit)) ;
Izatt, Louise (Guy's and St Thomas NHS Foundation Trust (Londres, Regne Unit)) ;
Chu, Carol (Yorkshire Regional Genetics Service (Leeds, Regne Unit)) ;
Davids, Rosemarie (Ferguson-Smith Centre for Clinical Genetics (Glasgow, Regne Unit)) ;
Ong, Kai-Ren (Birmingham Women's Hospital Healthcare NHS Trust (Birmingham, Regne Unit)) ;
Cook, Jackie (Sheffield Children's Hospital (Sheffield, Regne Unit)) ;
Douglas, Fiona (Newcastle Upon Tyne Hospitals NHS Trust (Newcastle, Regne Unit)) ;
Hodgson, Shirley (University of London. St George's Hospital) ;
Brewer, Carole (Royal Devon & Exeter Hospital (Exeter, Regne Unit)) ;
Morrison, Patrick J. (Northern Ireland Regional Genetics Centre (Belfast, Regne Unit)) ;
Porteous, Mary (South East of Scotland Regional Genetics Service (Edimburg, Regne Unit)) ;
Peterlongo, Paolo (Fondazione IRCCS Istituto Nazionale Tumori (Milà, Itàlia)) ;
Manoukian, Siranoush (Fondazione IRCCS INT (Milà, Itàlia)) ;
Peissel, Bernard (Fondazione IRCCS INT (Milà, Itàlia)) ;
Zaffaroni, Daniela (Fondazione IRCCS INT (Milà, Itàlia)) ;
Roversi, Gaia (Fondazione IRCCS INT (Milà, Itàlia)) ;
Barile, Monica (Istituto Europeo di Oncologia (Milà, Itàlia)) ;
Viel, Alessandra (Centro di Riferimento Oncologico (Aviano, Itàlia)) ;
Pasini, Barbara (University of Turin. Department of Genetics, Biology and Biochemistry (Torí, Itàlia)) ;
Ottini, Laura (Sapienza University of Rome. Department of Molecular Medicine) ;
Putignano, Anna Laura (University of Florence. Department of Clinical Physiopathology (Florència, Itàlia)) ;
Savarese, Antonella (Regina Elena Cancer Institute (Roma, Itàlia)) ;
Bernard, Loris (IEO. Department of Experimental Oncology (Milà, Itàlia)) ;
Radice, Paolo (Fondazione IRCCS Istituto Nazionale Tumori (Milà, Itàlia)) ;
Healey, Sue (Queensland Institute of Medical Research. Division of Genetics and Population Health (Brisbane, Austràlia)) ;
Spurdle, Amanda (Queensland Institute of Medical Research. Division of Genetics and Population Health (Brisbane, Austràlia)) ;
Chen, Xiaoqing (Queensland Institute of Medical Research. Division of Genetics and Population Health (Brisbane, Austràlia)) ;
Beesley, Jonathan (Queensland Institute of Medical Research. Division of Genetics and Population Health (Brisbane, Austràlia)) ;
Rookus, Matti A. (The Netherlands Cancer Institute. Department of Epidemiology (Amsterdam, Països Baixos)) ;
Verhoef, Senno (The Netherlands Cancer Institute. Family Cancer Clinic (Amsterdam, Països Baixos)) ;
Tilanus-Linthorst, Madeleine A. (Erasmus MC-Daniel den Hoed Cancer Center (Rotterdam, Països Baixos)) ;
Vreeswijk, Maaike P. (Leiden University Medical Center. Center for Human and Clinical Genetics (Leiden, Països Baixos)) ;
Asperen, Christi J. (Leiden University Medical Center. Center for Human and Clinical Genetics (Leiden, Països Baixos)) ;
Bodmer, Danielle (Radboud University Nijmegen Medical Center. Department of Human Genetics (Nijmegen, Països Baixos)) ;
Ausems, Margreet G. E. M. (University Medical Center Utrecht. Department of Medical Genetics (Utrecht, Països Baixos)) ;
van Os, Theo A. (Academic Medical Center, Department of Clinical Genetics (Amsterdam, Països Baixos)) ;
Blok, Marinus J. (University Hospital Maastricht. Department of Clinical Genetics (Maastricht, Països Baixos)) ;
Meijers-Heijboer, Hanne E. J. (VU Medical Center. Department of Clinical Genetics (Amsterdam, Països Baixos)) ;
Hogervorst, Frans B. L. (The Netherlands Cancer Institute. Family Cancer Clinic (Amsterdam, Països Baixos)) ;
Goldgar, David E. (University of Utah School of Medicine. Department of Dermatology (Salt Lake City, Estats Units d'Amèrica)) ;
Buys, Saundra (Huntsman Cancer Institute (Salt Lake City, Estats Units d'Amèrica)) ;
John, Esther M. (Cancer Prevention Institute of California (Fremont, Estats Units d'Amèrica)) ;
Miron, Alexander (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica). Department of Cancer Biology) ;
Southey, Melissa (The University of Melbourne. Melbourne School of Population Health (Austràlia)) ;
Daly, Mary B. (Fox Chase Cancer Center. Division of Population Science (Philadelphia, Estats Units d'Amèrica)) ;
Harbst, Katja (Lund University. Department of Oncology (Lund, Suècia)) ;
Borg, Åke (Lund University. Department of Oncology (Lund, Suècia)) ;
Rantala, Johanna (Karolinska University Hospital) ;
Barbany-Bustinza, Gisela (Karolinska University Hospital) ;
Ehrencrona, Hans (Uppsala University. Departament of Genetics and Pathology (Uppsala, Suècia)) ;
Stenmark-Askmalm, Marie (Hälsouniversitetet Universitetssjukhuset. Department of Oncology (Linköping, Suècia)) ;
Kaufman, Bella (Chaim Sheba Medical Center. The Institute of Oncology (Ramat Gan, Israel)) ;
Laitman, Yael (Chaim Sheba Medical Center (Israel)) ;
Milgrom, Roni (Chaim Sheba Medical Center (Israel)) ;
Friedman, Eitan (Chaim Sheba Medical Center (Israel)) ;
Domchek, Susan M. (University of Pennsylvania School of Medicine. Abramson Cancer Center (Philadelphia, Estats Units d'Amèrica)) ;
Nathanson, Katherine L. (University of Pennsylvania School of Medicine. Abramson Cancer Center (Philadelphia, Estats Units d'Amèrica)) ;
Rebbeck, Timothy R. (University of Pennsylvania School of Medicine. Abramson Cancer Center (Philadelphia, Estats Units d'Amèrica)) ;
Johannsson, Oskar Thor (20A Landspitali-LSH v/Hringbraut. Department of Oncology (Reykjavik, Islàndia)) ;
Couch, Fergus J. (Mayo Clinic. Department of Laboratory Medicine and Pathology (Rochester, Estats Units d'Amèrica)) ;
Wang, Xianshu (Mayo Clinic. Department of Laboratory Medicine and Pathology (Rochester, Estats Units d'Amèrica)) ;
Fredericksen, Zachary (Mayo Clinic. Department of Health Sciences Research (Rochester, Estats Units d'Amèrica)) ;
Cuadras, Daniel (Institut d'Investigació Biomèdica de Bellvitge) ;
Morros, Rosa (South East of Scotland Regional Genetics Service, Western General Hospital (Edimburg, Regne Unit)) ;
Pientka, Friederike K. (University of Lübeck. Center for Structural and Cell Biology in Medicine (Lübeck, Alemanya)) ;
Depping, Reinhard (University of Lübeck. Center for Structural and Cell Biology in Medicine (Lübeck, Alemanya)) ;
Caldés, Trinidad (Hospital Clínico San Carlos (Madrid)) ;
Osorio, Ana (Centro Nacional de Investigaciones Oncológicas) ;
Benítez, Javier (Centro Nacional de Investigaciones Oncológicas) ;
Bueren, Juan (Centro de Investigaciones Energéticas, Medioambientales, y Tecnológicas (Madrid, Espanya)) ;
Heikkinen, Tuomas (Helsinki University Central Hospital. Department of Obstetrics and Gynecology (Helsinki, Finlàndia)) ;
Surrallés i Calonge, Jordi (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ;
Pujana, Miguel Angel (Institut d'Investigació Biomèdica de Bellvitge) ;
Tominaga, Kaoru (The University of Texas Health Science Center at San Antonio) ;
Cerón, Julián (Institut d'Investigació Biomèdica de Bellvitge) ;
Antoniou, Antonis C. (University of Cambridge. Department of Public Health and Primary Care) ;
Fert Ferrer, Sandra (Hôtel Dieu Centre Hospitalier (Chambéry, França)) ;
Collonge-Rame, Marie-Agnès (Centre Hospitalier Universitaire de Besançon (Besançon, França)) ;
Mortemousque, Isabelle (Centre Hospitalier Universitaire Bretonneau (Tours, França)) ;
McGuffog, Lesley (University of Cambridge. Department of Public Health and Primary Care) ;
Chenevix-Trench, Georgia (Queensland Institute of Medical Research (Brisbane, Austràlia)) ;
Pereira-Smith, Olivia M. (The University of Texas Health Science Center at San Antonio) ;
Nevanlinna, Heli (Helsinki University Central Hospital. Department of Obstetrics and Gynecology (Helsinki, Finlàndia)) ;
Hamann, Ute (Deutsches Krebsforschungszentrum (Heidelberg, Alemanya)) ;
Torres, Diana (Pontificia Universidad Javeriana. Instituto de Genética Humana (Bogota, Colòmbia)) ;
Caligo, Maria Adelaide (University Hospital of Pisa (Pisa, Itàlia)) ;
Godwin, Andrew K. (University of Kansas Medical Center. Department of Pathology and Laboratory MedicineCenter (Kansas, Estats Units d'Amèrica)) ;
Imyanitov, Evgeny N. (N.N. Petrov Institute of Oncology. Laboratory of Molecular Oncology (Sant Petersburg, Rússia)) ;
Janavicius, Ramunas (Vilnius University Hospital Santariskiu Clinics. Hematology, Oncology and Transfusion Medicine Center (Vilnius, Lituània)) ;
Sinilnikova, Olga M. (Centre Hospitalier Universitaire de Lyon. Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents (Lyon, França)) ;
Stoppa-Lyonnet, Dominique (Institut Curie) ;
Mazoyer, Sylvie (Université Lyon 1. Cancer Research Center of Lyon (Lyon, França)) ;
Verny-Pierre, Carole (Université Lyon 1. Cancer Research Center of Lyon (Lyon, França)) ;
Castera, Laurent (Institut Curie) ;
de Pauw, Antoine (Institut Curie) ;
Bignon, Yves-Jean (Université de Clermont-Ferrand. Département d'Oncogénétique (Clermont-Ferrand, França)) ;
Uhrhammer, Nancy (Université de Clermont-Ferrand. Département d'Oncogénétique (Clermont-Ferrand, França)) ;
Peyrat, Jean-Philippe (Centre Oscar Lambret. Laboratoire d'Oncologie Moléculaire Humaine (Lille, França)) ;
Vennin, Philippe (Centre Oscar Lambret. Consultation d'Oncogénétique (Lille, França)) ;
The Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab) ;
The Netherlands Cancer Institute.
Hereditary Breast and Ovarian Cancer Group (HEBON) ;
University of Utah School of Medicine.
Breast Cancer Family Registry (Salt Lake City, Estats Units d'Amèrica) ;
Lund University.
Swedish Breast Cancer Study (Lund, Suècia) ;
Fédération Nationale des Centres de Lutte Contre le Cancer.
Groupe Génétique et Cancer (Lyon, França)
Introduction: Proteins encoded by Fanconi anemia (FA) and/or breast cancer (BrCa) susceptibility genes cooperate in a common DNA damage repair signaling pathway. To gain deeper insight into this pathway and its influence on cancer risk, we searched for novel components through protein physical interaction screens. [...]
2011 - 10.1186/bcr2862
Breast cancer research, Vol. 13, Núm. R40 (4 2011) -14
|
|